옵션 체인은 다양한 행사가격과 만기일에 대한 Baidu의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Baidu에 대한 시장 심리를 평가합니다..

Baidu (OTC:BAIDF) 주식, 옵션 체인

Baidu is the largest internet search engine in China with over 50% share of the search engine market in 2024 per web analytics firm, Statcounter. The firm generated 72% of core revenue from online marketing services from its search engine in 2023. Outside its search engine, Baidu is a technology-driven company and its other major growth initiatives are artificial intelligence cloud, video streaming services, voice recognition technology, and autonomous driving.

Palantir, Carvana, Enovix, Grab, Tesla: Why These 5 Stocks Are On Investors' Radars Today

Asia

Equities

News

Markets

BABA

ALIBABA GROUP HOLDING LTD by Alibaba Group Holding Limited

BABAF

BAIDF

JDCMF

TCEHY

XIACY

금요일(21일) 중국 기술주가 급등했다. 알리바바(OTC:BABAF)(NYSE:BABA)가 12% 이상 급등하는 등 투자자들이 긍정적인 실적 가이던스와 중국의 통화 정책 완화에 대한 기대감에 반응했다.

알리바바, 홍콩 거래에서 12% 이상 급등: 중국 지원책 기대 속 텐센트·샤오미 등 중국 기술주 동반 랠리

Baidu Inc

Trump Media &amp; Technology Group Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) shares are trading higher Monday after the company announced a <a href="https://www.benzinga.com/pressreleases/25/06/g46049824/trump-media-announces-share-repurchase-authorization">share repurchase authorization</a>.
What Happened: Trump Media&#8217;s board has authorized a buyback of up to $400 million of the company&#8217;s common stock. Any repurchases will be made on the open market and comprise either stock or warrants. 
&#8220;The Board took a vote of confidence in our Company, our stock, and our strategic plans. Since Trump Media now has approximately&nbsp;$3 billion&nbsp;on its balance sheet, we have the flexibility to take actions like this which support strong shareholder returns, as we continue exploring further strategic opportunities,&#8221; said Devin Nunes, chairman and CEO of Trump Media. 
Trump Media noted that any repurchases would be funded separately from the company&#8217;s previously announced Bitcoin treasury strategy. Trump Media <a href="https://www.benzinga.com/trading-ideas/movers/25/05/45620103/whats-going-on-with-trump-media-stock-tuesday-2">said</a> in May that it entered into subscription agreements with approximately 50 institutional investors for a private placement of approximately $2.3 billion in order to launch a Bitcoin strategy. 
Trump Media is the operator of Truth Social, Truth+ and Truth.Fi. The company was&nbsp;co-founded by President&nbsp;Donald Trump, whose family maintains a controlling stake.
Check This Out: <a href="https://www.benzinga.com/news/politics/25/06/46046249/mike-pence-lauds-trumps-decisive-leadership-on-the-historic-mission-against-irans-nuclear-program-i-couldnt-be-more-proud">Mike Pence Lauds Trump&#8217;s &#8216;Decisive Leadership&#8217; On The &#8216;Historic Mission&#8217; Against Iran&#8217;s Nuclear Program: &#8216;I Couldn&#8217;t Be More Proud&#8217;</a>
<h3 class="wp-block-heading">How To Buy DJT Stock</h3>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Trump Media's case, it is in the Communication Services sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
DJT Price Action: <a href="http://benzinga.com/quote/djt" target="_blank" rel="noreferrer noopener">Trump Media shares</a> were up 3.65% at $18.47 at the time of publication Monday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. Trump Media shares are down about 47% on a year-to-date basis.
Photo: rarrarorro/Shutterstock.

Buybacks

Movers

Trump Media Shares Move Higher After Board Approves $400 Million Buyback

Universal Technical Institute's Concorde Career Colleges And Marquis Continue Partnership To Address Demand For Licensed Practical Nurses In Oregon

D. Boral Capital analyst Jason Kolbert maintains Lineage Cell Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/LCTX#AMEX">LCTX</a>) with a Buy and maintains $2 price target.

Price Target

Analyst Ratings

LCTX

D. Boral Capital Maintains Buy on Lineage Cell Therapeutics, Maintains $2 Price Target

Multispectral imaging for high resolution monitoring and control of harmful algal blooms in coastal ecosystems
AgEagle Aerial Systems Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UAVS#NYSE">UAVS</a>), a leading provider of best-in-class unmanned aerial systems (UAS) and sensors for military, public safety, and commercial use, is pleased to announce JEPICO Corporation, a prominent environmental technology company based in Tokyo, Japan, has acquired a state-of-the-art RedEdge-P multispectral sensor. This sensor will be used to analyze and address red tide pollution, a critical environmental issue driven by cyanobacteria and harmful algal blooms (HABs) affecting Japan's coastal ecosystems.

UAVS

AgEagle Aerial Systems Says JEPICO Acquires RedEdge-P Multispectral Sensor

D. Boral Capital analyst Jason Kolbert maintains NRX Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRXP#NASDAQ">NRXP</a>) with a Buy and maintains $31 price target.

NRXP

D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $31 Price Target

<ul>
<li>HIMS</li>
<li>TSLA</li>
<li>CRCL</li>
<li>GLD</li>
<li>GOOGL</li>
<li>BULL</li>
<li>GOOG</li>
<li>NVO</li>
<li>AMD</li>
<li>UNH</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

Trading Ideas

BULL

CRCL

GOOG

GOOGL

Hims & Hers Health, Inc. Class A Common Stock

HIMS

TSLA

Top 10 Trending Stocks On WallStreetBets As Of June 23, 2025 (Via Swaggy Stocks)

Shares of Stellantis NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>) are trading lower by 2.3% to $9.20 Monday morning. The stock is down following the official appointment of Antonio Filosa as CEO.
What To Know: Filosa, who also retains oversight of North America and American brands, <a href="https://www.benzinga.com/pressreleases/25/06/n46046266/antonio-filosa-announces-new-stellantis-leadership-team-on-first-day-as-ceo">unveiled</a> his new Stellantis Leadership Team, a move aimed at aligning regional operations with brand and product strategies.
The revamped team includes key executives like Doug Ostermann as CFO with added M&amp;A duties, Jean-Philippe Imparato leading Enlarged Europe and Maserati and Emanuele Cappellano heading South America and commercial vehicles under Stellantis Pro One. 
Other notable roles include Davide Mele for product planning, Monica Genovese for purchasing and Scott Thiele in a newly created role overseeing supply chain operations.
The restructuring builds on earlier changes announced in February 2025 and <a href="https://www.benzinga.com/pressreleases/25/06/n46046266/antonio-filosa-announces-new-stellantis-leadership-team-on-first-day-as-ceo">emphasizes</a> localized decision-making and customer-focused innovation. Filosa described the team as &#8220;entrepreneurial&#8221; and &#8220;people-first,&#8221; highlighting their collective expertise across Stellantis&#8217; global footprint.
Meanwhile, former executives Maxime Picat and Béatrice Foucher are departing the company after years of service.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, STLA has a 52-week high of $21.05 and a 52-week low of $8.39.
Read Also: <a href="https://www.benzinga.com/news/travel/25/06/46045416/us-issues-worldwide-caution-after-strikes-on-irans-nuclear-sites-state-department-warns-of-airspace-closures-travel-chaos-and-rising-threats-to-americans-abroad">U.S. Issues Worldwide Caution After Strikes On Iran&#8217;s Nuclear Sites</a>
<h2 class="wp-block-heading">How To Buy STLA Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Stellantis&#8217; case, it is in the Consumer Discretionary sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
Image: Shutterstock

STLA

What's Going On With Stellantis (STLA) Stock?

Wedbush analyst Daniel Ives reiterates Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) with a Outperform and maintains $500 price target.

Reiteration

Wedbush Reiterates Outperform on Tesla, Maintains $500 Price Target

The cryptocurrency market is showing weakness at the start of the week, as geopolitical fears intensify with the <a href="https://www.benzinga.com/news/travel/25/06/46045416/us-issues-worldwide-caution-after-strikes-on-irans-nuclear-sites-state-department-warns-of-airspace-closures-travel-chaos-and-rising-threats-to-americans-abroad">U.S. stepping deeper into the Iran-Israel conflict</a>. Bitcoin is holding above $100,000 but remains under pressure after weekend volatility.
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$101,513.69</td>
<td>-0.95%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>$2,247.76</td>
<td>-0.57%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>$133.90</td>
<td>-0.46%</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>$1.99</td>
<td>-2.3%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.1518</td>
<td>-2.1%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00001079</td>
<td>+0.06%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul class="wp-block-list">
<li>IntoTheBlock data shows that Bitcoin and Ethereum&#8217;s large transaction volume increased 53.9% and 55.6%, respectively. However, daily active addresses for both witnessed a decline of 10% and 16.3%, respectively.</li>
<li>CoinGlass data shows that 181,115 traders were liquidated in the past 24 hours, with the total liquidations at $627.86 million.</li>
<li>SoSoValue data shows net inflows of $6.37 million (as of June 20) into spot Bitcoin ETFs while Spot Ethereum ETFs saw net outflows of $11.3 million.</li>
</ul>
Trader Notes: Crypto Seth <a href="https://x.com/seth_fin/status/1937062944484831422">says</a> Bitcoin's high-time-frame strategy remains to hold spot positions, but short-term action hinges on geopolitical developments. If Iran closes the Strait of Hormuz, oil price surges could spark a broader economic shock, potentially dragging crypto lower alongside global markets.
Crypto trader Jelle notes Bitcoin lost its 50-day moving average (MA) and closed back within a prior range, indicating a failed breakout. Reclaiming $105,000 quickly is crucial to avoid a sideways summer of stagnation and uncertainty. The next few days should reveal the market's direction.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> has lost the 50-day MA &#8211; and closed back below the key support area. Back inside the range now, either we reclaim $105k quickly, or we&#39;re indeed in for sideways summer. Should know more later this week. <a href="https://t.co/yvOsQW5rnz">pic.twitter.com/yvOsQW5rnz</a>
&mdash; Jelle (@CryptoJelleNL) <a href="https://twitter.com/CryptoJelleNL/status/1937029528351830504?ref_src=twsrc%5Etfw">June 23, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Crypto trader Kevin flags Dogecoin&#8217;s battle to hold above the weekly 200 SMA &amp; EMA, along with the macro 0.382 Fib level. The critical support zone to watch is $0.1434–$0.1265. Holding this range keeps DOGE's bullish structure intact.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Weekly 200 SMA and EMA are must holds for <a href="https://twitter.com/hashtag/Dogecoin?src=hash&amp;ref_src=twsrc%5Etfw">#Dogecoin</a> along with the macro .382 and down trending support. The key range is .1434-.1265 <a href="https://twitter.com/hashtag/Crypto?src=hash&amp;ref_src=twsrc%5Etfw">#Crypto</a> <a href="https://twitter.com/hashtag/Altcoins?src=hash&amp;ref_src=twsrc%5Etfw">#Altcoins</a> <a href="https://t.co/1jCMBRRWCu">pic.twitter.com/1jCMBRRWCu</a>
&mdash; Kevin (@Kev_Capital_TA) <a href="https://twitter.com/Kev_Capital_TA/status/1936957509593678016?ref_src=twsrc%5Etfw">June 23, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Ted Pillows <a href="https://x.com/TedPillows/status/1937073144411406661">observes</a> Ethereum has bounced off the $2,100 support, but to turn bullish, ETH must reclaim $2,350. Failure to break out may lead to a retest of prior lows or even deeper correction.
Cas Abbe <a href="https://x.com/cas_abbe/status/1937061182004768998">sees</a> Solana bouncing cleanly off its support — a bullish signal suggesting strong buyer interest. He believes the pending ETF approval has yet to be priced in, positioning SOL for a potential rally in July.
Read Next:
<a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46036394/bitcoin-quietly-entered-a-new-era-in-march-heres-whats-really-behind-it">Bitcoin Quietly Entered A New Era In March: Here&#8217;s What&#8217;s Really Behind It</a>
Photo: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$DOGE

$ETH

$SHIB

$SOL

$XRP

Bitcoin, Ethereum, XRP, Dogecoin Weaken On Iran-Israel Tensions – Reclaim $105,000 Or Brace For Sideways Summer

Terreno Realty Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRNO#NYSE">TRNO</a>), an acquirer, owner and operator of industrial real estate in six major coastal U.S. markets, acquired an industrial property located in Santa Ana, California on June 20, 2025 for a purchase price of approximately $49.5 million.
The property consists of one industrial distribution building containing approximately 134,000 square feet on 12.1 acres of industrial zoned land. The property is currently 100% leased to a major home improvement retailer and operated as a retail location. The property is at 3500 West MacArthur Boulevard, adjacent to I-405 in Orange County, and provides seven dock-high and three grade-level loading positions. The estimated stabilized cap rate is 5.7%.

TRNO

Terreno Realty Acquires Industrial Property In Santa Ana For Purchase Price Of ~$49.5M

<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="900" height="600" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/23080815/Lovol-0623-900x600-1.png" alt="" class="wp-image-14735" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/23080815/Lovol-0623-900x600-1.png 900w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/23080815/Lovol-0623-900x600-1-300x200.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/23080815/Lovol-0623-900x600-1-768x512.png 768w" sizes="(max-width: 900px) 100vw, 900px" /></figure>
China's leading maker of agricultural equipment has filed for a Hong Kong listing, forecasting the market for its products is set for explosive growth
Key Takeaways:
<ul class="wp-block-list">
<li>Weichai Lovol has filed for a Hong Kong IPO that could raise around $500 million, providing valuable cash for expansion as China modernizes its agricultural sector</li>
<li>The company expects the Chinese market for intelligent agricultural equipment to grow by more than 40% annually over the next few years, boosted by government policy</li>
</ul>
China is on the cusp of an agricultural revolution, according to&nbsp;Weichai Lovol Intelligent Agricultural Technology Co. Ltd., which submitted its application for a Hong Kong IPO at the end of last week.
While that assertion by China's leading seller of tractors and harvesters sounds a bit self-serving, it could actually be true, which would position Weichai Lovol for some explosive growth. While much is written about China's desire to be self-sufficient in high-tech products like microchips, the country's similar desire for self-sufficiency in food production is probably just as strong, if not stronger.
The recent U.S.-China trade war has highlighted how much China relies on imports to feed not only its 1.4 billion citizens, but also its huge herds of cattle, pigs and other livestock. To mitigate that reliance, the country is implementing wide-ranging policies to modernize its agricultural sector. The aim is to transform the country from one that was composed of hundreds of thousands of small family-run farms just a couple of decades ago to a more Western-style system of mega-farms using modern agricultural methods and machinery to boost efficiency.
Weichai Lovol looks well positioned to benefit from that transition, thanks to its dominant position in China's overall agricultural machinery market, and its even more dominant spot in the smart agricultural machinery market. The company looks relatively well run, based on financial information contained in its&nbsp;<a href="https://www1.hkexnews.hk/app/sehk/2025/107465/documents/sehk25062001529.pdf">listing document</a>, though its growth of the last two years isn't particularly spectacular.
One notable place where it's lacking is in its margins, which are notably lower than its global peers. That suggests Weichai Lovol may not be as efficient as its global rivals, and also probably reflects the fact that pricing pressure in China is greater than other global markets.
"China has identified intelligent agricultural machinery as a strategic tool to safeguard food security. Through systematic policy arrangements, the nation is accelerating the industry's upgrade," Weichai Lovol said in its listing document. It cited a couple of government plans, the "Plan for Accelerating the Construction of an Agricultural Powerhouse (2024-2035)," and the "National Smart Agriculture Action Plan (2024-2028)," as reflecting the country's determination to modernize its agricultural sector over the next few years.
Such support almost certainly means the government will throw huge sums of money at the sector in many forms, from grants to low-interest loans, to help its modernization. As that happens, China's market for intelligent agricultural machinery is expected to grow by an average of 43.6% annually over the next five years from just 11.8 billion yuan in 2024 to 104 billion yuan in 2023, according to third-party market data in the listing document.
That kind of growth will raise the penetration rate for smart agricultural equipment to 33.1% in 2030 from just 7.2% last year, roughly matching the global penetration rate that was 31.6% last year and is expected to rise to 34.7% by 2030. As China builds up a new generation of mega-farms using intelligent agricultural equipment, its agricultural workforce is expected to drop to just 30 million people by 2050, from 160 million in 2024.
<h4 class="wp-block-heading">China reliant</h4>
Based in Eastern China's Shandong province, Weichai Lovol is currently 61%-owned by Hong Kong-listed Weichai Power (2338.HK), which first announced its plan to spin off its agricultural equipment arm in April. In its own&nbsp;<a href="https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0620/2025062001764.pdf">separate announcement</a>&nbsp;last Friday, Weichai Power called the decision to spin off Lovol "consistent with the governmental policies in improving core competitiveness of state-owned assets and enhancing international influence."
Such a spinoff indeed looks like a good idea at this time, since it would provide Lovol with some major new financial resources to accelerate its development of intelligent agricultural equipment to feed the coming boom. The company has hired leading domestic investment bank CICC as its sole underwriter, suggesting the listing will be sizable.
With the company likely to be valued at $2 billion to $3 billion, based on our estimates, the listing could raise around $500 million. That would nearly double Lovol's existing cash, which totaled 4.78 billion yuan ($665 million) at the end of last year.
While Weichai Lovol is forecasting big growth in the next five years, there's no indication of that coming boom in its financials from the past three years. The company's revenue grew by 18.4% last year to 17.4 billion yuan from 14.7 billion yuan, which is certainly respectable but not eye-popping. The company's revenue actually contracted 8% in 2023, as it blamed a decrease in its sales of harvesting machines without giving much additional explanation.
Tractors and harvesting machines are the company's two main product lines, the former accounting for 52% of sales last year and the latter for 41%. Notably, harvesting machines aren't doing as well as tractors, dropping from their previous level of supplying 46% of the company's revenue in 2022. The company's exports are growing but still relatively limited, rising to about 10% of revenue last year from about 6% in 2022.
Its profit last year rose to 957 million yuan from 871 million yuan in 2023, representing a 9.8% increase.
As we noted earlier, Weichai Lovol's gross margins are one area where it notably lags its global peers. That figure stood at 13.2% in the last two years, or less than half of&nbsp;Deere &amp; Co.'s&nbsp;(DE.US) figure of about 28% and also well below the 21% for&nbsp;CNH&nbsp;(CNH.US). Deere currently trades at a price-to-earnings (P/E) ratio of 25, while CNH trades a bit lower at 16. A ratio in that range would value Weichai Loval at anywhere from 15.3 billion yuan at the lower end to as much as 23.9 billion yuan.
The company is China's clear leader in both the overall agricultural equipment and intelligent agricultural equipment markets, with 21.2% share and 46%, respectively. That should position it well if China's coming agricultural revolution really materializes, which seems likely. Though we should also note that the company's domestic and global peers will also get attracted by such explosive growth, which could sharply heat up competition in this up-and-coming field.

IPOs

Opinion

China's Push to Modernize Agriculture Could Boost This Stock

D. Boral Capital analyst Jason Kolbert maintains Medicus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDCX#NASDAQ">MDCX</a>) with a Buy and maintains $27 price target.

MDCX

D. Boral Capital Maintains Buy on Medicus Pharma, Maintains $27 Price Target

New patents received for the treatment of epilepsy and for the sublingual delivery of nicotine
KELOWNA, BC / <a href="https://www.accessnewswire.com/">ACCESS Newswire</a> / June 23, 2025 / Lexaria Bioscience Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEXX#NASDAQ">LEXX</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEXXW#NASDAQ">LEXXW</a>) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to announce that it has received 2 new international patents. This now brings Lexaria's total worldwide patent portfolio to 50.
Lexaria has been granted a new patent in Australia within its patent family #24, Compositions and Methods for Treating Epilepsy. This broadens Lexaria's intellectual property protection for the use of its DehydraTECH&#x2122; enhanced processing technology related to the treatment of epilepsy outside of the USA, where a strong patent portfolio of 6 existing patents has already been built. This new patent will expire in 2044.
Lexaria has also been granted a new patent in Japan within its patent family #20, Compositions and Methods for Sublingual Delivery of Nicotine. This patent joins already-existing patents within the same family in both the USA and Canada. This new patent will expire in 2043.
The epilepsy drug market was US$9.5 billion in 2023 and is <a href="https://pr.report/bpwt">expected to reach sales of over $15 billion</a> by 2032. Approximately 50 million people in the US alone are affected by epilepsy.

LEXX

LEXXW

Lexaria Bioscience Receives Two New Patents For Treatment Of Epilepsy And For Sublingual Delivery Of Nicotine

D. Boral Capital analyst Jason Kolbert maintains Cormedix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRMD#NASDAQ">CRMD</a>) with a Buy and maintains $15 price target.

CRMD

D. Boral Capital Maintains Buy on Cormedix, Maintains $15 Price Target

Indonesia Energy Corp Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INDO#NYSE">INDO</a>) shares are surging 35% to $6.85 Monday morning, fueled by escalating geopolitical turmoil in the Middle East and mounting concerns over global oil supply disruptions.
What To Know: The U.S. State Department has <a href="https://www.benzinga.com/news/travel/25/06/46045416/us-issues-worldwide-caution-after-strikes-on-irans-nuclear-sites-state-department-warns-of-airspace-closures-travel-chaos-and-rising-threats-to-americans-abroad">issued</a> a Worldwide Caution alert Sunday as U.S.-Iran tensions flared following U.S. airstrikes on Iranian nuclear sites. Iran's parliament responded by voting to potentially close the Strait of Hormuz, a vital route for nearly 20% of global oil shipments.
The move amplifies fears of <a href="https://www.benzinga.com/news/politics/25/06/46047021/iran-threatens-strait-of-hormuz-after-us-bombs-its-nuclear-sites-shipping-traffic-plunges">supply chain disruptions</a>, driving up oil prices during Monday trading. As a result, small-cap oil exploration firms like Indonesia Energy have drawn speculative investor interest across social media.
What Else: Indonesia Energy, headquartered in Jakarta, engages in upstream oil and gas exploration, with key assets in the Kruh Block on Sumatra Island. The company benefits directly from surging oil prices, given its production-linked revenue model and growth potential in a tightening energy market.
With U.S. citizens evacuating Israel, Iranian airspace closed and diplomatic ties fraying, the heightened risk premium on oil is catalyzing investor movement toward energy stocks, especially volatile, low-float plays like INDO.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, INDO has a 52-week high of $6.24 and a 52-week low of $2.06.
Read Also: <a href="https://www.benzinga.com/markets/market-summary/25/06/46047848/us-stock-futures-rise-as-markets-shrug-off-iran-strike-fallout-worst-is-now-in-the-rear-view-mirror-says-top-analyst">U.S. Stocks Likely To Open Lower As Iran Vows Retaliation After U.S. Strike</a>
<h2 class="wp-block-heading">How To Buy INDO Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Indonesia Energy Corp&#8217;s case, it is in the Energy sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
Image: Shutterstock

INDO

Indonesia Energy (INDO) Stock Soars Amid Middle East Tensions, Oil Disruption Fears

WIIM

RZLV

Rezolve AI shares are trading higher after the company announced it will join the Russell 2000 and Russell 3000 indexes

JMP Securities analyst Mitch Germain reiterates Orion Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONL#NYSE">ONL</a>) from Market Perform to Market Perform.

JMP Securities Reiterates Market Perform on Orion Propertiesto Market Perform

Hims &amp; Hers Health Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) shares are trading lower Monday after Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) terminated its collaboration <a href="https://www.benzinga.com/pressreleases/25/06/n46049309/novo-nordisk-terminates-collaboration-with-hims-hers-health-inc-due-to-concerns-about-their-illega">with the company</a>. 
What Happened: Novo Nordisk announced Monday that it will no longer be working with Hims &amp; Hers Health. As a result, the company will no longer have direct access to Wegovy through the NovoCare Pharmacy. 
Novo Nordisk alleged in a press release that Hims &amp; Hers Health has failed to follow laws that prohibit mass sales of compounded drugs under the false appearance of &#8220;personalization&#8221; and has used deceptive marketing with disregard for patient safety.
&#8220;Novo Nordisk is firm on our position and protecting patients living with obesity. When patients are prescribed semaglutide treatments by their licensed healthcare professional or a telehealth provider, they are entitled to receive authentic, FDA-approved and regulated Wegovy,&#8221; said&nbsp;Dave Moore, executive vice president of Novo Nordisk&#8217;s U.S. operations.
&#8220;We will work with telehealth companies to provide direct access to Wegovy&nbsp;that share our commitment to patient safety – and when companies engage in illegal sham compounding that jeopardizes the health of Americans, we will continue to take action.&#8221;
The news comes after the U.S. Food and Drug Administration's (FDA)&nbsp;said in April that Semaglutide, the active ingredient in popular weight-loss drugs like Wegovy, could&nbsp;<a href="https://www.fda.gov/drugs/drug-safety-and-availability/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize" target="_blank" rel="noreferrer noopener">no longer be offered</a>&nbsp;in compounded drugs by outsourcing facilities.
Shares of Hims &amp; Hers Health fell as the FDA action took effect. Hims &amp; Hers sells cheaper versions of popular weight-loss drugs, known as compounded drugs. Regulators allow compounded versions of drugs to enter the market to meet demand when there is a shortage. The company generated over $225 million in revenue in 2024 from its GLP-1 product.
Novo Nordisk on Monday said it&#8217;s &#8220;deeply concerned&#8221; and will continue to take proactive measures to keep U.S. patients safe from &#8220;knock-off drugs made with foreign illicit active pharmaceutical ingredients.&#8221;
HIMS Price Action:&nbsp;<a href="http://benzinga.com/quote/hims" target="_blank" rel="noreferrer noopener">Hims &amp; Hers Health shares</a>&nbsp;were down 23.9% at $48.90 at the time of publication Monday, according to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/health-care/25/06/46048974/eli-lillys-investigational-oral-pill-shows-weight-loss-benefits-with-lingering-side-effect-concerns">Eli Lilly&#8217;s Investigational Oral Pill Shows Weight Loss Benefits With Lingering Side Effect Concerns</a></li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/06/46048611/5-stock-picks-last-week-from-wall-streets-most-accurate-analysts-7">5 Stock Picks Last Week From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>
Photo: Lori Butcher/Shutterstock.

Hims & Hers Health Stock Is Tumbling Monday: What's Happening?

Telsey Advisory Group analyst Joseph Feldman maintains Kroger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KR#NYSE">KR</a>) with a Outperform and raises the price target from $73 to $82.

Telsey Advisory Group Maintains Outperform on Kroger, Raises Price Target to $82

JMP Securities analyst Jonathan Wolleben reiterates Structure Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GPCR#NASDAQ">GPCR</a>) with a Market Outperform and maintains $89 price target.

Comments

Baidu

Baidu (BAIDF) 옵션

No option chain data available. Please try again later

뉴스

파트너 / 기고자

벤징가 글로벌